NCLT Directs Venmax Drugs Shareholder Meeting For Hatri Pharma Merger
Venmax Drugs and Pharmaceuticals Ltd 路 Others (Uncategorized) 路 08 Sept 2026, 7:43 pm
NCLT Directs Venmax Drugs Shareholder Meeting For Hatri Pharma Merger Venmax Drugs and Pharmaceuticals received an NCLT Hyderabad Bench order dated 7th Sep'26 regarding its composite scheme of amalgamation with Hatri Pharma Private Limited. NCLT directed Venmax to convene an equity shareholders' meeting on 24th Oct'26 at 12:30 PM via video conferencing, while dispensing with meetings for Hatri Pharma's shareholders and creditors of both entities. Under the proposed share exchange ratio, Venmax will allot 1 fully paid equity share (Rs 10 face value) for every 1 equity share held in Hatri Pharma.
Original exchange filing (PDF)
More announcements from Venmax Drugs and Pharmaceuticals Ltd
- Statement of Deviation and Variation for the Quarter ended September 30, 2026. 路 12 Nov 2026
- Unaudited Financial Results for the Quarter and Half Year ended September 30, 206. 路 12 Nov 2026
- Unaudited Financial Results for the Quarter and Half Year Ended September 30, 2026 路 12 Nov 2026
- Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve Unaudited .... 路 12 Nov 2026
- Venmax Drugs and Pharmaceuticals Limited has submitted the Exchange a copy if Scrutinizer report along with voting results of court convened General Meeting held on October 24, 2026. 路 27 Oct 2026
- Venmax Drugs and Pharmaceuticals Limited has informed the Bombay Stock Exchange regarding Proceedings of court convened General Meeting held today i.e. October 24, 2026. 路 24 Oct 2026
- Voting Results along with the Scrutinizers Report of the 37th Annual General Meeting of the Company held on 26th September 2026 through VC/OAVM. 路 28 Sept 2026
- Summary of the proceedings of 37th Annual General Meeting of the shareholders held at 12.30 P.M. through video conferencing mode. 路 26 Sept 2026
